Educational programming at the Napa Pain Conference is led by the brightest minds in Pain and Neuroscience.
The Napa Pain Conference is designed by Neurovations Education, who work with our stellar Program Committee — leaders in clinical medicine, medical device manufacture, pharmaceutical and business development — to design a one-of-a-kind program. Our Innovation happens here.

Call For Abstracts

Submissions Open Through May 8, 2017
Abstract submission guidelines

The 24th Annual Napa Pain Conference

The Napa Pain Conference welcomes physicians, nurses, pharmacists, psychologists and other health care professionals to learn the latest information necessary to diagnose, treat, and manage acute and chronic pain, and associated comorbidities.

Generalists and specialists will benefit from a wide range of topics and faculty presenting basic, translational and the latest treatment advancements.

  • Thursday, August 17, 2017

    Pre-Conference Sessions

    Regenerative Medicine & Intraspinal Drug Delivery

    AGENDA AVAILABLE SOON
  • Friday, August 18, 2017

    The 24th Annual Napa Pain Conference

    The 24th Annual Napa Pain Conference, Day One

    AGENDA AVAILABLE SOON
  • Saturday, August 19, 2017

    The 24th Annual Napa Pain Conference

    The 24th Annual Napa Pain Conference, Day Two

    AGENDA AVAILABLE SOON
  • Sunday, August 20, 2017

    The 24th Annual Napa Pain Conference

    The 24th Annual Napa Pain Conference, Day Three

    Agenda Available Soon

Missed Us Last Year?

Download the Agenda from NPC23 | August 2016

Education Objectives

The Napa Pain Conference is a forum where attendees discuss and learn the latest evidence for the treatment of pain. Participants receive new information and strategies to integrate advancements into their clinical practice.

TARGET AUDIENCE
Physicians, generalist and specialists, including but not limited to: internal medicine, primary care physicians, anesthesiologists, pain management and interventional pain management, emergency medicine, and any physician seeking to better address chronic or acute pain within their patients.

Provided education will also be of benefit to researchers, physician assistants, nurses, allied health professionals, and other health professions.

It has become important for healthcare providers to implement multifaceted interventions to treat chronic pain, reducing the risks for opioid over-prescribing, misuse, and diversion, without limiting appropriate access to treatment. As with every rapidly evolving specialty, existing practitioners must learn how to implement best practices related to advancements in patient care, patient adherence, assessment, and evaluation, and prescriber and patient communication.

GAP ANALYSIS
Chronic pain is exceedingly prevalent. In the United States, between 20 to 30% of the population are afflicted with chronic or recurring pain. Primary care physicians (PCP) treat approximately 52% of chronic pain patients (IOM 2011), yet only 46% of PCPs consider themselves sufficiently trained in prescribing opioids (J. Opioid Management).

More than 100,000 people have died in the United States from prescribed opioids, directly or indirectly, since the 1990s when the drugs started to be used more widely for non-cancer chronic pain (Neurology 2014).

Interventional and diversion-proof treatments may help combat rising opioid morbidity and mortality rates. At the same time, providers must understand and utilize the latest evidence-based measures and treatment plans for the use of pharmacotherapies, including opiates. any agent outside of the labeled indications.

When an unlabeled use of a commercial product, or investigational use not yet approved for any purpose is discussed during an educational activity, the speaker is required to disclose that the product is not labeled for use under discussion or that the product is still investigational. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of SpectrumCare, or Neurovations Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

LEARNING OBJECTIVES
Two sets of learning objectives are provided for the 23rd Napa Pain Conference.

Objectives for CME-certified content
As a result of participating in this activity, learners will be able/better able to:
• Differentiate treatment approaches medical vs. interventional for neuropathic pain,
• Relate what was previously known about the effects of spinal cord stimulation for the treatment of chronic pain with new scientific findings on pain thresholds and sensory perceptions, and the efficacy of high-frequency spinal cord stimulation,
• Overcome patient barriers to treatment for patients who would benefit from including mindfulness-based practices in the treatment of their chronic pain,
• Implement, as necessary, changes to their utilization of opioid therapy for the treatment of chronic pain,
• Evaluate patients who will benefit from regenerative medicine, and be able to refer such patients or prepare to include regenerative medicine within their practice, and
• Compare the use of HF10 therapy to current treatment options.

Objectives for educational, non-CME certified content
As a result of participating in this activity, learners will be able/better able to:
• Identify appropriate candidates for neurostimulation to manage
chronic pain,
• Utilize minimally-invasive procedures, such as radiofrequency denervation and cryoanalgesia, as necessary,
• Contrast the risks and benefits of spinal cord stimulation with regards to ongoing patient treatment, and
• Diagnose patients who may benefit from dorsal root ganglion (DRG) stimulation.

2017 Program Committee

Eric Grigsby, MD, MBA

Napa Pain Conference Chair
President and Founder, Neurovations Clinical Research and Education Founder and Medical Director, Napa Pain Institute and the Spine and Pain Center of Kauai

Timothy Davis, MD

Founder and Medical Director, Orthopedic Pain Specialists
Physiatrist, Cedars-Sinai Spine Center

Leo Kapural, MD, PhD

Clinical Director, Wake Forest University Health Sciences Chronic Pain Center, Carolinas Pain Institute and Center for Clinical Research

Lawrence Poree, MD

Professor and Director of Neuromodulation Service, Department of Anesthesia and Perioperative Care, University of California at San Francisco

David Provenzano, MD

President of Pain Diagnostics and Interventional Care

Samir Sheth, MD

Assistant Professor, Department of Anesthesiology and Pain Medicine
Co-Director of Neuromodulation at UC Davis

B. Todd Sitzman, MD, MPH

Medical Director of Advanced Pain Therapy

Lisa J. Stearns, MD

Founder and Medical Director of Center for Pain and Supportive Care

Harold J. Cordner, MD

Pain Management Specialist, Forida Pain Management Associates

Penney Cowan

Founder and CEO of American Chronic Pain Association


Invited Faculty List

Every year, the Napa Pain Conference is honored to welcome the world's finest clinicians, researchers, and scientists to lead our lectures and panel discussions. With the help of our Scientific Committee, we are proud to welcome the finest clinicians, researchers, scientists, and industry innovators to our stage.
Timothy Davis, MD
Aaron Calodney, MD
Eric Grigsby, MD, MBA
Leo Kapural, MD, PhD
Sten Lindahl, MD, PhD, FRCA
Lawrence Poree, MD, PhD, MPH
David Provenzano, MD
Samir J. Sheth, MD
B. Todd Sitzman, MD, MPH
Elliot Krames, MD
Sean Li, MD
Avinash Ramchandani, MD, MBA
Gregory Scherrer, PhD, PharmD
Warren M. Zapol, MD
Howard Pitluk, MD, MPH, FACS